ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

CLSA Leadership & Member Companies Visit Capitol Hill to Urge Medical Device Tax Repeal

By Molly Fishman & Jenny Nieto
Sept. 21, 2019

CLSA leadership participated in an executive advocacy day on Capitol Hill on Sept. 19, that was coordinated by our national medtech association partner, AdvaMed. The purpose of the fly-in was to advocate for the full and permanent repeal of the 2.3 percent excise tax on medical device revenue that will go back into effect on January 1, 2020 if Congress does not act before the end of the year.

CLSA’s CEO Mike Guerra and Board Chair Melinda Richter (Global Head, Johnson & Johnson Innovation – JLABS), along with executives from CLSA member companies BD and Edwards Lifesciences, participated in the important fly-in. The group met with the following members and staff from the California Congressional Delegation to impress upon the urgency to repeal the tax as soon as possible: Reps. Ami Bera, MD (D-Sacramento), Lou Correa (D-Santa Ana), Katie Hill (D-Simi Valley), Mike Levin (D-San Juan Capistrano), Katie Porter (D-Irvine), Harley Rouda (D-Newport Beach), Jackie Speier (San Francisco/San Mateo Counties), and Eric Swalwell (D-East Bay). You can see tweets of CLSA’s participation in the AdvaMed fly-in here.

During the same week, CLSA successfully secured freshman California Congressman Gil Cisneros (D-Yorba Linda) as a cosponsor of the bill to fully repeal the medical device tax. That bill, H.R. 2207, now has the support of 26 bipartisan members of the California congressional delegation, including 5 of 7 freshman members, which in total represents over 10% of the overall support for the bill. We encourage you to take action to help repeal the tax by visiting our Digital Advocacy Center to send a letter, tweet or share our new campaign today.

Questions? Please contact Molly Fishman, CLSA’s Director of Federal Government Relations (mfishman@califesciences.org).